Position in GILD
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,369,778
-$169,424 QoQ
Shares Held
10,842
-1.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#953
of 2,266 holders
Holding Since
Jun 2020
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sargent Investment Group, LLC holds $34,963,451 across 9 Drug Manufacturers - General names. GILD ranks #6 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
46,728 | $11,758,633 | |
| 2 | JNJ |
Johnson & Johnson
|
33,156 | $8,420,629 | |
| 3 | LLY |
ELI LILLY & Co
|
5,913 | $7,092,230 | |
| 4 | MRK |
Merck & Co., Inc.
|
25,863 | $3,323,395 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
36,270 | $2,089,877 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
10,842 | $1,369,778 | |
| 7 | AMGN |
Amgen Inc
|
1,276 | $462,065 | |
| 8 | PFE |
Pfizer Inc
|
9,550 | $229,964 |
All Filings in GILD
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,369,778 | 10,842 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,539,202 | 11,044 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,177,199 | 9,591 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,257,408 | 11,328 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $996,943 | 8,992 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $718,912 | 6,416 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $466,837 | 5,054 | Shares | Sole | 2025-01-27 | |
| 2020-09-30 | $279,615 | 4,425 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $425,785 | 5,534 | Shares | Sole | 2020-08-11 | |
| No filing history on record for this holder in this stock. | ||||||